Filing Details
- Accession Number:
- 0001127602-12-034074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-17 11:45:22
- Reporting Period:
- 2012-12-13
- Filing Date:
- 2012-12-17
- Accepted Time:
- 2012-12-17 11:45:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224663 | Melissa Lueke | 3471 River Hills Drive Cincinnati OH 45244 | Exec Vp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-13 | 5,250 | $0.00 | 119,265 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-13 | 5,250 | $19.88 | 114,015 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-13 | 15,750 | $0.00 | 129,765 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-14 | 15,750 | $19.83 | 114,015 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-12-13 | 5,250 | $0.00 | 5,250 | $4.53 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-12-13 | 15,750 | $0.00 | 15,750 | $16.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-12-02 | No | 4 | M | Direct | |
| 0 | 2016-11-15 | No | 4 | M | Direct |
Footnotes
- Prices range from $19.8640 per share to $19.9021 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- Shares sold represent previously-held shares acquired from earlier option exercises, rather than the shares acquired from the 12/13/12 exercise of options granted on 11/15/06 reflected hereon.
- Prices range from $19.7700 per share to $19.8850 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- These options became fully vested in November 2007.
- These options became fully vested in November 2010.
Billionaire Hedge Funds
